Insulinoma
📧 Sign up to get email alerts when something new happens for Insulinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Diagnosing and Treating Low Blood Sugar Levels
Sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases, this trial aims to improve diagnosis and treatment of low…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Clinical Study of 18F-Exendin-4 in Insulinoma
A clinical trial evaluating 18F-Exendin-4 for imaging insulinoma has completed.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions
Clinical trial update on recruiting for a study evaluating endoscopic ultrasound-guided radiofrequency ablation of upper gastrointestinal tr…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: DOTATOC PET/CT for Imaging NET Patients
ClinicalTrials.gov entry describes a DOTATOC PET/CT imaging study for neuroendocrine tumors, sponsored by the British Columbia Cancer Agency…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Clinical trial evaluating 18F-L-fluoro-DOPA PET/CT to localize focal pancreatic lesions in people with hyperinsulinemic hypoglycemia, includ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-03-14Clinical Trial Update: An Exploratory Study of 68Ga-DOTA-SEMA in Preoperative Precise Imaging of Patients with Glucagon-Like Peptide-1 Receptor (GLP1R) Positive Insulinomas [NA]
This clinical trial update shows that the NCT06759740 study evaluating 68Ga-DOTA-SEMA for preoperative imaging of GLP1R-positive insulinomas…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
A clinical trial update indicates that a study evaluating GLP-1 receptor PET/CT imaging is currently recruiting to investigate GLP-1R-relate…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of everolimus and vatalanib in patients with advanced solid tumors, including several neuroendocrin…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma [Phase 1]
Phase 1 clinical trial evaluating fluorodopa F-18 as an imaging tracer for congenital hyperinsulinism and insulinoma. The study is currently…
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating temozolomide with or without capecitabine in advanced pancreatic neuroendocrine tumors, including subtypes such as …
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating regorafenib in advanced or metastatic neuroendocrine tumors has been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating 68Ga-NODAGA-exendin-4 PET/CT for diagnostic imaging in insulinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer [Phase 2]
Phase 2 study of temsirolimus in combination with bevacizumab in advanced endometrial, ovarian, liver, carcinoid, and pancreatic neuroendocr…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: New Imaging Procedure for the Localisation of Insulinoma [NA]
This clinical trial evaluated a new imaging procedure to localize insulinomas in patients with endogenous hyperinsulinaemic hypoglycaemia, a…
-
CLINICAL_TRIALS withdrawal · 2017-07-19Clinical Trial Update: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of dovitinib lactate for pancreatic neuroendocrine tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma [Phase 1]
Phase 1 clinical trial evaluating the combination of Cixutumumab, Everolimus, and Octreotide acetate in patients with advanced low- to inter…
-
CLINICAL_TRIALS research · 2015-09-25Clinical Trial Update: 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis [EARLY_Phase 1]
This early Phase 1 trial evaluates a Ga-68 labeled exendin-4 PET/CT agent for localizing insulinomas and diagnosing nesidioblastosis. The st…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients
Completed study evaluating whole-body imaging with Indium-111 labeled exendin-4 to visualize insulin-secreting tumors in insulinoma patients…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in patients with progressive metastatic neuroendocrine tumors has completed; results were posted…
-
CLINICAL_TRIALS research · 2014-04-23Clinical Trial Update: EUS-guided Ethanol Ablation of an Insulinoma [NA]
This document reports a clinical trial update on using endoscopic ultrasound-guided ethanol ablation to treat an insulinoma; the study statu…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial update evaluating gefitinib in patients with progressive/metastatic neuroendocrine tumors has completed. The study en…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of romidepsin for locally advanced or metastatic neuroendocrine tumors was terminated; the document lists the conditions studi…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Laparoscopy to Remove Pancreatic Tumors (Insulinomas) [NA]
A completed clinical trial evaluated laparoscopic removal of pancreatic insulinoma tumors, sponsored by the National Institute of Diabetes a…